BridgeBio Pharma Quick Ratio 2018-2024 | BBIO

Historical quick ratio values for BridgeBio Pharma (BBIO) over the last 10 years.
BridgeBio Pharma Quick Ratio Historical Data
Date Current Assets - Inventory Current Liabilities Quick Ratio
2024-06-30 $0.00B $0.13B 0.00
2024-03-31 $0.00B $0.14B 0.00
2023-12-31 $0.00B $0.14B 0.00
2023-09-30 $0.00B $0.11B 0.00
2023-06-30 $0.00B $0.11B 0.00
2023-03-31 $0.00B $0.10B 0.00
2022-12-31 $0.00B $0.12B 0.00
2022-09-30 $0.00B $0.12B 0.00
2022-06-30 $0.00B $0.14B 0.00
2022-03-31 $0.00B $0.10B 0.00
2021-12-31 $0.00B $0.14B 0.00
2021-09-30 $0.00B $0.10B 0.00
2021-06-30 $0.00B $0.13B 0.00
2021-03-31 $0.00B $0.10B 0.00
2020-12-31 $0.00B $0.10B 0.00
2020-09-30 $0.00B $0.08B 0.00
2020-06-30 $0.00B $0.09B 0.00
2020-03-31 $0.00B $0.07B 0.00
2019-12-31 $0.00B $0.06B 0.00
2019-09-30 $0.00B $0.04B 0.00
2019-06-30 $0.00B 0.00
2019-03-31 $0.00B 0.00
2018-12-31 $0.00B 0.00
2018-09-30 $0.00B 0.00
2017-12-31 $0.00B 0.00
Sector Industry Market Cap Revenue
Medical Medical - Generic Drugs $4.791B $0.009B
BridgeBio Pharma Inc. discovers, develops and innovates drugs for genetic diseases. The Company's product platform consists of Mendelian, Oncology and Gene therapy. Its product pipeline includes BBP-265, BBP-831, BBP-631 and BBP-454 which are in clinical stage. BridgeBio Pharma Inc. is based in CA, United States.
Stock Name Country Market Cap PE Ratio
Teva Pharmaceutical Industries (TEVA) Israel $20.902B 7.10
Dr Reddy's Laboratories (RDY) India $12.399B 18.57
Bausch Health Cos (BHC) Canada $3.597B 2.61
Amphastar Pharmaceuticals (AMPH) United States $2.469B 13.82
Supernus Pharmaceuticals (SUPN) United States $1.872B 377.44
Taysha Gene Therapies (TSHA) United States $0.314B 51.00
Personalis (PSNL) United States $0.270B 0.00
Assembly Biosciences (ASMB) United States $0.107B 0.00
Acasti Pharma (GRCE) Canada $0.031B 0.00
Sol-Gel Technologies (SLGL) Israel $0.014B 0.00
Evoke Pharma (EVOK) United States $0.005B 0.00
Teligent (TLGT) United States $0.000B 0.00